REVIEW 2 cited by
Revolutionizing Pharma: Unveiling the AI and LLM Trends in the Pharmaceutical Industry
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
Signed reviews
read the original abstract
This document offers a critical overview of the emerging trends and significant advancements in artificial intelligence (AI) within the pharmaceutical industry. Detailing its application across key operational areas, including research and development, animal testing, clinical trials, hospital clinical stages, production, regulatory affairs, quality control and other supporting areas, the paper categorically examines AI's role in each sector. Special emphasis is placed on cutting-edge AI technologies like machine learning algorithms and their contributions to various aspects of pharmaceutical operations. Through this comprehensive analysis, the paper highlights the transformative potential of AI in reshaping the pharmaceutical industry's future.
Forward citations
Cited by 2 Pith papers
-
Regulator-Manufacturer AI Agents Modeling: Mathematical Feedback-Driven Multi-Agent LLM Framework
A multi-agent LLM simulation with feedback differential equations is proposed to model how medical device manufacturers adapt to regulatory changes, but its predictions are not validated against real data.
-
From Text to Discovery: How Large Language Models Are Reshaping Research Across Scientific and Humanistic Disciplines
LLMs accelerate research workflows from idea generation to writing but introduce challenges like hallucination, bias, opacity, and ten systemic risks requiring new governance frameworks.
Discussion (0). Continue with ORCID to comment.